
Gilead Sciences' top products based on revenue 2020-2022
This statistic shows the top products of biopharmaceutical company Gilead Sciences from 2020 to 2022, based on revenue. Gilead Sciences Inc. is headquartered in California and is specialized in discovering, developing and commercializing therapeutics. In 2022, Gilead Sciences' COVID-19 treatment Veklury (remdesivir) generated some 3.9 billion U.S. dollars in revenue, a significant decrease compared to 5.6 billion in 2021.